BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Nektar

About Nektar:

Nektar Therapeutics is a drug delivery products based company that provides a portfolio of technologies that will enable it and its pharmaceutical partners to improve drug performance throughout the drug development process. The Company is focused on three main technologies: Nektar Advanced PEGylation Technology, Nektar Pulmonary Technology and Nektar Supercritical Fluids Technology. These technologies are designed to improve either the performance of a drug molecule (such as improving bioavailability, safety, efficacy, stability or targeting) or how the drug is delivered (such as enabling a new dosage form or delivery profile that improves how the therapeutic can treat patients).

 

DETAILED PIPELINE

 

More on Nektar


Home Page for Nektar

Key Statistics for Nektar

Basic Chart for Nektar

Analyst Opinion

Analysts Estimates

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com